Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

7.55
-0.1450-1.88%
Post-market: 7.550.00000.00%17:52 EDT
Volume:708.13K
Turnover:5.38M
Market Cap:129.49M
PE:-0.60
High:7.79
Open:7.70
Low:7.42
Close:7.70
52wk High:24.49
52wk Low:7.42
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.67
T/O Rate:4.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.58
PE(LYR):-0.52

Loading ...

Alliance Global Partners Sticks to Their Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
Jun 01

Tonix presents real-world claims analysis showing persistent opioid prescribing in US fibromyalgia patients

Reuters
·
May 29

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire
·
May 29

Tonix Pharmaceuticals publishes TNX-1500 data in Journal of Clinical Immunology

TIPRANKS
·
May 27

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

GlobeNewswire
·
May 27

Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch strategy

Reuters
·
May 27

Analysts Offer Insights on Healthcare Companies: Daxor (DXR) and Tonix Pharma (TNXP)

TIPRANKS
·
May 26

Tonix Pharmaceuticals presents data from analysis of adults with fibromyalgia

TIPRANKS
·
May 26

Tonix presents real-world U.S. claims analysis of 261,776 fibromyalgia patients at ISPOR 2026

Reuters
·
May 26

Press Release: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Dow Jones
·
May 26

Tonix Pharmaceuticals posts TNX-4800 Lyme disease prevention presentation

Reuters
·
May 18

Tonix publishes TNX-1500 xenotransplantation workshop presentation

Reuters
·
May 18

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)

TIPRANKS
·
May 18

Tonix publishes investor deck highlighting TONMYA fibromyalgia launch strategy

Reuters
·
May 15

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

GlobeNewswire
·
May 14

Tonix Pharmaceuticals to present at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

GlobeNewswire
·
May 13

Analysts’ Top Healthcare Picks: Dexcom (DXCM), Tonix Pharma (TNXP)

TIPRANKS
·
May 12

Tonix Pharmaceuticals reports Q1 EPS ($2.93) vs. ($2.84) last year

TIPRANKS
·
May 12

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12